vs
花花公子（PLBY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是花花公子的2.0倍（$69.8M vs $34.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 10.3%，领先373.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 4.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 11.0%）
花花公子集团（Playboy, Inc.）起源于1953年由休·海夫纳联合合伙人在美国芝加哥创立，初始部分资金来自海夫纳母亲提供的1000美元贷款，是美国知名生活方式与娱乐内容品牌，旗下核心《花花公子》杂志同时发行电子版与纸质版。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PLBY vs RIGL — 直观对比
营收规模更大
RIGL
是对方的2.0倍
$34.9M
营收增速更快
RIGL
高出17.0%
4.2%
净利率更高
RIGL
高出373.8%
10.3%
两年增速更快
RIGL
近两年复合增速
11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.9M | $69.8M |
| 净利润 | $3.6M | $268.1M |
| 毛利率 | 73.3% | 91.5% |
| 营业利润率 | 7.9% | 33.2% |
| 净利率 | 10.3% | 384.0% |
| 营收同比 | 4.2% | 21.2% |
| 净利润同比 | 128.6% | 1769.2% |
| 每股收益（稀释后） | $0.05 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLBYRIGL
| Q4 25 | $34.9M | $69.8M | ||
| Q3 25 | $29.0M | $69.5M | ||
| Q2 25 | $28.1M | $101.7M | ||
| Q1 25 | $28.9M | $53.3M | ||
| Q4 24 | $33.5M | $57.6M | ||
| Q3 24 | $29.4M | $55.3M | ||
| Q2 24 | $24.9M | $36.8M | ||
| Q1 24 | $28.3M | $29.5M |
净利润PLBYRIGL
| Q4 25 | $3.6M | $268.1M | ||
| Q3 25 | $460.0K | $27.9M | ||
| Q2 25 | $-7.7M | $59.6M | ||
| Q1 25 | $-9.0M | $11.4M | ||
| Q4 24 | $-12.5M | $14.3M | ||
| Q3 24 | $-33.8M | $12.4M | ||
| Q2 24 | $-16.7M | $-1.0M | ||
| Q1 24 | $-16.4M | $-8.2M |
毛利率PLBYRIGL
| Q4 25 | 73.3% | 91.5% | ||
| Q3 25 | 76.0% | 93.2% | ||
| Q2 25 | 65.4% | 95.6% | ||
| Q1 25 | 68.6% | 91.7% | ||
| Q4 24 | 70.8% | 89.9% | ||
| Q3 24 | 61.0% | 85.5% | ||
| Q2 24 | 67.8% | 92.4% | ||
| Q1 24 | 55.8% | 93.1% |
营业利润率PLBYRIGL
| Q4 25 | 7.9% | 33.2% | ||
| Q3 25 | 4.7% | 40.9% | ||
| Q2 25 | -20.9% | 60.1% | ||
| Q1 25 | -21.7% | 23.9% | ||
| Q4 24 | -13.3% | 28.9% | ||
| Q3 24 | -96.0% | 25.4% | ||
| Q2 24 | -37.0% | 1.2% | ||
| Q1 24 | -31.5% | -23.6% |
净利率PLBYRIGL
| Q4 25 | 10.3% | 384.0% | ||
| Q3 25 | 1.6% | 40.2% | ||
| Q2 25 | -27.3% | 58.6% | ||
| Q1 25 | -31.3% | 21.5% | ||
| Q4 24 | -37.4% | 24.9% | ||
| Q3 24 | -114.7% | 22.5% | ||
| Q2 24 | -66.9% | -2.8% | ||
| Q1 24 | -58.1% | -27.9% |
每股收益（稀释后）PLBYRIGL
| Q4 25 | $0.05 | $14.11 | ||
| Q3 25 | $0.00 | $1.46 | ||
| Q2 25 | $-0.08 | $3.28 | ||
| Q1 25 | $-0.10 | $0.63 | ||
| Q4 24 | $-0.13 | $0.82 | ||
| Q3 24 | $-0.45 | $0.70 | ||
| Q2 24 | $-0.23 | $-0.06 | ||
| Q1 24 | $-0.23 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.8M | $155.0M |
| 总债务越低越好 | $174.2M | $52.5M |
| 股东权益账面价值 | $18.4M | $391.5M |
| 总资产 | $292.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 9.48× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PLBYRIGL
| Q4 25 | $37.8M | $155.0M | ||
| Q3 25 | $27.5M | $137.1M | ||
| Q2 25 | $19.6M | $108.4M | ||
| Q1 25 | $23.7M | $77.1M | ||
| Q4 24 | $30.9M | $77.3M | ||
| Q3 24 | $9.5M | $61.1M | ||
| Q2 24 | $16.9M | $49.1M | ||
| Q1 24 | $19.0M | $49.5M |
总债务PLBYRIGL
| Q4 25 | $174.2M | $52.5M | ||
| Q3 25 | $176.8M | $60.0M | ||
| Q2 25 | $177.5M | $60.0M | ||
| Q1 25 | $176.3M | $60.0M | ||
| Q4 24 | $176.6M | $60.0M | ||
| Q3 24 | $200.0M | $60.0M | ||
| Q2 24 | $196.3M | $60.0M | ||
| Q1 24 | $193.4M | $60.0M |
股东权益PLBYRIGL
| Q4 25 | $18.4M | $391.5M | ||
| Q3 25 | $3.8M | $117.6M | ||
| Q2 25 | $-17.5M | $81.9M | ||
| Q1 25 | $-11.4M | $18.6M | ||
| Q4 24 | $-7.7M | $3.3M | ||
| Q3 24 | $-15.7M | $-14.6M | ||
| Q2 24 | $15.7M | $-29.9M | ||
| Q1 24 | $29.5M | $-31.7M |
总资产PLBYRIGL
| Q4 25 | $292.4M | $513.6M | ||
| Q3 25 | $278.3M | $242.5M | ||
| Q2 25 | $264.1M | $206.7M | ||
| Q1 25 | $270.6M | $176.0M | ||
| Q4 24 | $284.7M | $164.0M | ||
| Q3 24 | $271.5M | $139.4M | ||
| Q2 24 | $301.8M | $128.4M | ||
| Q1 24 | $309.1M | $126.5M |
负债/权益比PLBYRIGL
| Q4 25 | 9.48× | 0.13× | ||
| Q3 25 | 46.86× | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | 12.51× | — | ||
| Q1 24 | 6.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | — |
| 自由现金流率自由现金流/营收 | 3.2% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 0.39× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-1.0M | — |
8季度趋势，按日历期对齐
经营现金流PLBYRIGL
| Q4 25 | $1.4M | $22.0M | ||
| Q3 25 | $10.1M | $24.0M | ||
| Q2 25 | $-3.9M | $30.5M | ||
| Q1 25 | $-7.6M | $-893.0K | ||
| Q4 24 | $161.0K | $14.5M | ||
| Q3 24 | $-6.5M | $21.7M | ||
| Q2 24 | $-3.0M | $302.0K | ||
| Q1 24 | $-9.8M | $-5.0M |
自由现金流PLBYRIGL
| Q4 25 | $1.1M | — | ||
| Q3 25 | $9.8M | — | ||
| Q2 25 | $-4.3M | — | ||
| Q1 25 | $-7.7M | — | ||
| Q4 24 | $-401.0K | — | ||
| Q3 24 | $-7.0M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-10.3M | — |
自由现金流率PLBYRIGL
| Q4 25 | 3.2% | — | ||
| Q3 25 | 33.8% | — | ||
| Q2 25 | -15.2% | — | ||
| Q1 25 | -26.5% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | -23.7% | — | ||
| Q2 24 | -14.8% | — | ||
| Q1 24 | -36.5% | — |
资本支出强度PLBYRIGL
| Q4 25 | 0.8% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 2.1% | — |
现金转化率PLBYRIGL
| Q4 25 | 0.39× | 0.08× | ||
| Q3 25 | 22.02× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLBY
| Transferred At Point In Time | $22.2M | 64% |
| Trademark Licensing | $6.5M | 19% |
| Related Party | $5.0M | 14% |
| Other | $1.1M | 3% |
RIGL
暂无分部数据
